Conexeu Sciences is trading 5.57% up at $4.70, as broader markets move higher ahead of the Federal Reserve’s September 16 decision.
- No new company-specific announcement explaining the move was identified; September 14–16 H.C. Wainwright conference participation was previously announced.
- Biotech-sector weakness contrasts with the gain, suggesting broader market positioning and rebound activity after September 15’s 11.00% decline are more likely supporting factors.